Abstract: Embodiments of systems, methods, and apparatuses for heterogeneous computing are described. In some embodiments, a hardware heterogeneous scheduler dispatches instructions for execution on one or more plurality of heterogeneous processing elements, the instructions corresponding to a code fragment to be processed by the one or more of the plurality of heterogeneous processing elements, wherein the instructions are native instructions to at least one of the one or more of the plurality of heterogeneous processing elements.

Abstract: The present invention related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.

Abstract: In an embodiment, a processor includes: a fetch circuit to fetch instructions, the instructions including a sum of squared differences (SSD) instruction; a decode circuit to decode the SSD instruction; and an execution circuit to, during an execution of the decoded SSD instruction, generate an SSD output vector based on a plurality of input vectors, the SSD output vector including a plurality of squared differences values. Other embodiments are described and claimed.

Abstract: Systems, methods, and apparatuses relating to instructions to reset software thread runtime property histories in a hardware processor are described. In one embodiment, a hardware processor includes a hardware guide scheduler comprising a plurality of software thread runtime property histories; a decoder to decode a single instruction into a decoded single instruction, the single instruction having a field that identifies a model-specific register; and an execution circuit to execute the decoded single instruction to check that an enable bit of the model-specific register is set, and when the enable bit is set, to reset the plurality of software thread runtime property histories of the hardware guide scheduler.

Abstract: The present invention is related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The present invention related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.

Abstract: The present invention is related to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses.

Abstract: There are described methods for the prophylaxis or treatment of pain in a mammal wherein the method comprising administering to the mammal an effective amount of a pain inhibitor comprising a pain inhibiting peptide having an amino acid sequence of more than 6 contiguous arginine residues, or a physiologically acceptable salt of the peptide. The pain inhibitor can be administered in combination with at least one analgesic and/or at least one anti-inflammatory drug. Pharmaceutical compositions comprising the pain inhibitor together with at least one analgesic and/or at least one anti-inflammatory drug are also provided. The pain may, for example, be selected from one or more of neuropathic pain, inflammatory pain, idiopathic pain and nociceptive pain.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: Disclosed is a vehicle speed limiter for use with a vehicle throttle system comprising a mechanically actuable throttle member, an engine speed controller, and a throttle signal unit in data communication with an engine speed controller and operably coupled to the throttle member so as to generate an electronic throttle signal in functional response to the degree of actuation of the throttle member, and to transmit a throttle signal to the engine speed controller whereby the engine speed is controlled; the vehicle speed limiter comprising a vehicle speed sensor (15) to obtain a signal indicative of vehicle speed; a GPS system (30), operable to provide a speed limit applicable for a present position of the vehicle; a comparator to compare the speed sensor (15) output with the speed limit provided from the GPS system (30); a throttle signal modifier unit (23) acting on the output of a throttle signal unit in use when fitted in conjunction with a vehicle throttle system to modify a generated throttle signal so t

Abstract: The invention relates generally to conveying systems, for moving work pieces from work station to work station including conveyors which generally move at a constant speed and include load carrying units which can be coupled for movement therewith between work stations and uncoupled from the conveyor so that they will be stationary at the work stations while work is done on a work piece carried by the load carrying units. More particularly, the present invention pertains to improved systems, methods, and apparatuses for providing locomotion and control to a conveyor system including surface-mounted drive system and adjustable, automatic take-up system with floating drive chassis. The present invention also pertains to elevated conveyor systems comprising many of the same components as the surface-mounted conveyor systems.

Abstract: There is provided peptides for inhibiting growth of cancer cells, the peptides comprising the amino acid sequence RxKxKxxxxR wherein K and R are respectively lysine and arginine amino acid residues, each x is independently an amino acid, and 5 wherein the peptide has 50% or less amino acid sequence identity with the amino acid sequence RSKAKNPLYR (SEQ ID. No. 2). Each x amino acid may independently be an amino acid residue selected from the group consisting of alanine (A), valine (V), leucine (L), isoleucine (I), threonine (T) and serine (S) amino acid residues. There is also provided chimeric proteins incorporating a peptide of the amino acid sequence 10 RxKxKxxxxR, nucleic acids encoding for the peptide, expression vectors including a nucleic acid encoding the peptide for expression of the peptide, and methods for use of the peptide for inhibiting growth of cancer cells.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The invention relates generally to conveying systems, for moving work pieces from work station to work station including conveyors which generally move at a constant speed and include load carrying units which can be coupled for movement therewith between work stations and uncoupled from the conveyor so that they will be stationary at the work stations while work is done on a work piece carried by the load carrying units. More particularly, the present invention pertains to improved systems, methods, and apparatuses for providing locomotion and control to a conveyor system including surface-mounted drive system and adjustable, automatic take-up system with floating drive chassis. The present invention also pertains to elevated conveyor systems comprising many of the same components as the surface-mounted conveyor systems.